Last10K.com

21St Century Oncology Holdings, Inc. (RTSX) SEC Filing 10-K Annual report for the fiscal year ending Wednesday, December 31, 2014

21St Century Oncology Holdings, Inc.

CIK: 1503518 Ticker: RTSX

Exhibit 99.1

 

 

21ST CENTURY ONCOLOGY HOLDINGS, INC.

 

21st Century Oncology Contact:

Investor Contact:

Richard Lewis

The Ruth Group

SVP, CFO for U.S. Operations

Nick Laudico

239-931-7281

646-536-7030

richard.lewis@21co.com

nlaudico@theruthgroup.com

 

 

 

Courtney Dugan

 

646-536-7024

 

cdugan@theruthgroup.com

 

21ST CENTURY ONCOLOGY HOLDINGS INC. REPORTS FOURTH QUARTER AND FULL YEAR 2014 FINANCIAL RESULTS

 

Fourth Quarter 2014 Highlights:

 

·                  Total pro-forma revenues of $269.5  million, a 28.8% year-over-year increase

·                  7th consecutive quarter of growth in same store freestanding treatments per day, up 2.3% year-over-year

·                  4th consecutive quarter of Pro Forma Adjusted EBITDA margin expansion — 13.8% of total pro-forma revenues

·                  International cases increased 5.0% versus prior year period

·                  OnCure Holdings, Inc. (“Oncure”) and South Florida Radiation Oncology (“SFRO”) continue to perform ahead of expectations

 

Full Year 2014 Highlights:

 

·                  Pro-forma revenues surpass $1.0 billion, increasing 22.5%

·                  Domestic same store treatments per day increased 2.6%

·                  International revenues approaching $100 million, cases increased 10.4%

·                  Pro Forma Adjusted EBITDA of $150.9 million

·                  Reduced debt by $200 million with proceeds from Canada Pension Plan Investment Board (“CPPIB”) investment

 

Recent Developments:

 

·                  Entered into new region of Northwestern U.S. through joint venture with Northwest Cancer Clinic, LLC (“NWCC”) in January, 2015

·                  SFRO added two centers, enhancing its coordination of care and ability to leverage resources

·                  Established formal affiliations with the University of Florida (“UF”) and the University of California Los Angeles (“UCLA”)

 


The following information was filed by 21St Century Oncology Holdings, Inc. (RTSX) on Wednesday, March 18, 2015 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate 21St Century Oncology Holdings, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by 21St Century Oncology Holdings, Inc..

Continue

Assess how 21St Century Oncology Holdings, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

21St Century Oncology Holdings, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2015 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Cash Flows (parenthetical)
Consolidated Statements Of Changes In Equity
Consolidated Statements Of Operations And Comprehensive Loss
Accrued Expenses
Accrued Expenses (details)
Accrued Expenses (tables)
Acquisitions And Other Arrangements
Acquisitions And Other Arrangements (narrative) (details)
Acquisitions And Other Arrangements (schedule Of Estimated Future Amortization Expense For The Acquired Amortizable Intangible Assets) (details)
Acquisitions And Other Arrangements (schedule Of Preliminary Intangible Assets Included In Net Identifiable Assets) (details)
Acquisitions And Other Arrangements (schedule Of The Allocation Of The Purchase Price) (details)
Acquisitions And Other Arrangements (schedule Of Unaudited Pro Forma Financial Information) (details)
Acquisitions And Other Arrangements (summary Of Allocation Of The Aggregate Purchase Price, Including Assumed Liabilities) (details)
Acquisitions And Other Arrangements (tables)
Capital Lease Arrangements
Capital Lease Arrangements (details)
Capital Lease Arrangements (tables)
Commitments And Contingencies
Commitments And Contingencies (future Minimum Annual Lease Commitments) (details)
Commitments And Contingencies (narrative) (details)
Commitments And Contingencies (outstanding Letters Of Credit) (details)
Commitments And Contingencies (tables)
Equity Investments In Joint Ventures
Equity Investments In Joint Ventures (narrative) (details)
Equity Investments In Joint Ventures (schedule Of The Condensed Financial Position) (details)
Equity Investments In Joint Ventures (schedule Of The Condensed Results Of Operations) (details)
Equity Investments In Joint Ventures (summary Of The Changes In The Equity Investment In The Unconsolidated Joint Ventures) (details)
Equity Investments In Joint Ventures (tables)
Fair Value Of Financial Instruments
Fair Value Of Financial Instruments (narrative) (details)
Fair Value Of Financial Instruments (schedule Of Fair Value Debt Instruments Based On Level 2) (details)
Fair Value Of Financial Instruments (schedule Of Items Measured At Fair Value On Recurring Basis) (details)
Fair Value Of Financial Instruments (tables)
Goodwill And Intangible Assets
Goodwill And Intangible Assets (narrative) (details)
Goodwill And Intangible Assets (schedule Of Accumulated Impairment Losses) (details)
Goodwill And Intangible Assets (schedule Of Changes In The Carrying Amount Of Goodwill) (details)
Goodwill And Intangible Assets (schedule Of Components Of Intangible Assets) (details)
Goodwill And Intangible Assets (schedule Of Estimated Future Amortization Expense) (details)
Goodwill And Intangible Assets (summary Of Impairment Charges Relating To Goodwill And Trade Name) (details)
Goodwill And Intangible Assets (tables)
Income Taxes
Income Taxes (narrative) (details)
Income Taxes (reconciliation Of Statutory Tax Rate To Effective Tax Rate) (details)
Income Taxes (schedule Of Deferred Tax Assets And Liabilities) (details)
Income Taxes (schedule Of Reconciliation Of Gross Unrecognized Tax Benefits) (details)
Income Taxes (schedule Of Significant Components Of Income Tax Provision) (details)
Income Taxes (schedule Of Valuation Allowance) (details)
Income Taxes (tables)
Liquidity
Liquidity (details)
Long-term Debt
Long-term Debt (mdllc Credit And Guaranty Agreement) (details)
Long-term Debt (purchase Money Note Purchase Agreement) (details)
Long-term Debt (schedule Of Company's Long-term Debt) (details)
Long-term Debt (schedule Of Financial Covenants Compliance Under The Revolving Credit Facility) (details)
Long-term Debt (schedule Of Maturities Of Long-term Debt Obligations) (details)
Long-term Debt (senior Secured Credit Facility) (details)
Long-term Debt (senior Secured Notes) (details)
Long-term Debt (senior Secured Second Lien Notes) (details)
Long-term Debt (senior Subordinated Notes) (details)
Long-term Debt (tables)
Long-term Debt (term Loan A And B Facilities) (details)
Organization And Basis Of Presentation
Organization And Basis Of Presentation (details)
Other Income And Loss
Other Income And Loss (impairment Loss) (details)
Property And Equipment
Property And Equipment (details)
Property And Equipment (tables)
Real Estate Subject To Finance Obligation
Real Estate Subject To Finance Obligation (narrative) (details)
Real Estate Subject To Finance Obligation (schedule Of Future Payments Of The Finance Obligation) (details)
Real Estate Subject To Finance Obligation (schedule Of Net Book Values Of Real Estate Subject To Finance Obligation) (details)
Real Estate Subject To Finance Obligation (tables)
Reconciliation Of Total Equity And Noncontrolling Interests
Reconciliation Of Total Equity And Noncontrolling Interests (details)
Reconciliation Of Total Equity And Noncontrolling Interests (tables)
Redeemable Preferred Stock (narrative) (details)
Redeemable Preferred Stock (schedule Of Changes To Series A Preferred Stock) (details)
Related Party Transactions (details)
Related-party Transactions
Retirement And Deferred Compensation Plans
Retirement And Deferred Compensation Plans (assumptions Used To Determine Net Periodic Pension Benefit Cost) (details)
Retirement And Deferred Compensation Plans (changes In Projected Benefit Obligation And Fair Value Of Plan Assets) (details)
Retirement And Deferred Compensation Plans (fair Value Of Total Plan Assets By Major Asset Category) (details)
Retirement And Deferred Compensation Plans (narrative) (details)
Retirement And Deferred Compensation Plans (schedule Of Amounts Recognized In Other Comprehensive Income (loss)) (details)
Retirement And Deferred Compensation Plans (schedule Of Expected Benefit Payments) (details)
Retirement And Deferred Compensation Plans (schedule Of Net Benefit Costs) (details)
Retirement And Deferred Compensation Plans (tables)
Segment And Geographic Information
Segment And Geographic Information (narrative) (details)
Segment And Geographic Information (schedule Of Financial Information By Geographic Segment) (details)
Segment And Geographic Information (schedule Of Reconciliation Of The Company's Reportable Segment Profit And Loss) (details)
Segment And Geographic Information (tables)
Stock Option Plan And Restricted Stock Grants
Stock Option Plan And Restricted Stock Grants (narrative) (details)
Stock Option Plan And Restricted Stock Grants (summary Of Units Activity Under The Plan) (details)
Stock Option Plan And Restricted Stock Grants (tables)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (narrative) (details)
Summary Of Significant Accounting Policies (policy)
Summary Of Significant Accounting Policies (schedule Of Components Of Accumulated Other Comprehensive Loss) (details)
Summary Of Significant Accounting Policies (schedule Of Current Foreign Currency Derivative Agreements) (details)
Summary Of Significant Accounting Policies (schedule Of Inventories) (details)
Summary Of Significant Accounting Policies (schedule Of Major Asset Classifications And Useful Lives) (details)
Summary Of Significant Accounting Policies (summary Of The Activity In The Allowance For Doubtful Accounts) (details)
Summary Of Significant Accounting Policies (tables)
Supplemental Consolidating Financial Information
Supplemental Consolidating Financial Information (narrative) (details)
Supplemental Consolidating Financial Information (schedule Of Consolidating Balance Sheet) (details)
Supplemental Consolidating Financial Information (schedule Of Consolidating Statement Of Cash Flows) (details)
Supplemental Consolidating Financial Information (schedule Of Consolidating Statements Of Operations And Comprehensive Income (loss)) (details)
Supplemental Consolidating Financial Information (tables)
Unaudited Quarterly Financial Information
Unaudited Quarterly Financial Information (details)
Unaudited Quarterly Financial Information (tables)
Ticker: RTSX
CIK: 1503518
Form Type: 10-K Annual Report
Accession Number: 0001047469-15-002890
Submitted to the SEC: Fri Mar 27 2015 5:05:58 PM EST
Accepted by the SEC: Fri Mar 27 2015
Period: Wednesday, December 31, 2014
Industry: Offices And Clinics Of Doctors Of Medicine

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/rtsx/0001047469-15-002890.htm